Newsletter Edition #356 [The Files Brief]
Subscribe Now!
Readers,
In this quick update we bring you communication from the WHO over the last few days.
In addition, we also bring
Newsletter Edition #162 [Treaty Talks]
Subscribe Now!
Readers,
In this edition, we bring you a quick update on the extensive discussion on the Pathogen Access Benefit Sharing system at the
Newsletter Edition #161 [Treaty Talks]
Subscribe Now!
Readers,
Multilateralism is important, but cannot be an end in itself: this seems to be the message that WHO member states sent out
Newsletter Edition #159 [Treaty Talks]
Subscribe Now!
Readers,
WHO member states are meeting this week in Geneva once again in an effort to bridge positions in the negotiations on the
Newsletter Edition #156 [Treaty Talks]
Readers,
The negotiations on the Pathogen Access Benefit Sharing system at the WHO, is turning out to be a contest on "Who Blinks First&
Newsletter Edition #155 [Treaty Talks]
Readers,
What is symphony to some, is cacophony to others.
The negotiations on the Pathogen Access Benefit Sharing Mechanisms have registered intense activity by civil
Newsletter Edition #154 [Treaty Talks]
Readers,
Many fault multilateralism for its pace. But one of the interesting aspects of multilateralism is also its unpredictability. We also know that while in
Newsletter Edition #153 [Treaty Talks]
Readers,
We are sharing a guest essay today, ahead of the negotiations on the Pathogen Access Benefit Sharing system at the WHO, that begin tomorrow.
Newsletter Edition #152 [Treaty Talks]
Readers,
Countries will decide next week on who gets access to medical products during health emergencies, and how preparedness and response are determined in the
Newsletter Edition #151 [Treaty Talks]
Readers,
Developing countries have been pushing for the access to technology to make medical products, to better prepare for, and respond to health emergencies. This
Newsletter Edition #150 [Treaty Talks]
Readers,
In today's edition, we bring you an analysis on biosecurity in the context of the current negotiations on the Pathogen Access Benefit